Mission Statement
To transform the lives of people with epilepsy and associated psychiatric disorders in under-resourced areas of the world through diagnosis, treatment, and education.
Financial Overview — FY 2023
$250K
Annual Budget
$163K
Total Revenue
$146K
Total Expenses
N/A
Net Assets
1
Employees
Program Expense Ratio
N/A
Fundraising Efficiency
N/A
Operating Reserve
N/A
Liability-to-Asset
N/A
Revenue Diversification
N/A
Executive Compensation
$0
CharityAI™ Evaluation — 2025
75 / 10057
Financial
77
Reliability
90
Effectiveness
80
Impact
Financial Strength (30%)
57
Reliability & Transparency (20%)
77
Program Effectiveness (25%)
90
Impact & Outcomes (25%)
80
50,000 served annually
$6 per beneficiary
2 programs
3 staff
IRS Verified Form 990 on File 90% Data Complete
Impact
2 programs| Outcome / Program | People Served | Cost / Service | # Completed | Duration |
|---|---|---|---|---|
| Providing anti-seizure medication for safety, stability, education, employment | 20,000 | $10.00 | — | Per Year |
| Epilepsy education and anti-stigma programs in African Schools | 30,000 | $1.67 | — | Per Year |
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $163K | $146K | N/A | — | 1 |
| 2022 | $71K | $69K | N/A | — | 1 |
| 2021 | $172K | $85K | N/A | — | 1 |
Donor Reviews
No reviews yet
Be the first to share your experience with this organization.